GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic
diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.
( Total: 21 Current Stock Recommendations )
Arena Pharmaceuticals, Inc.   (21)
Sell 19% Hold 38% Buy 43%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy ARNA
down 50.18 %

Rating:
Buy ARNA
down 50.18 %

Rating:
Hold ARNA

Rating:
Buy ARNA
down 69.95 %

Rating:
Sell ARNA
up 238.86 %

Rating:
Sell ARNA
up 61.13 %

Rating:
Hold ARNA

Rating:
Hold ARNA
Arena Pharmaceuticals, Inc. (ARNA) rated Neutral by Davenport
Friday,  Sep 17, 2010  9:25 AM ET

Rating:
Sell ARNA
up 61.13 %

Rating:
Hold ARNA
up 76.02 %

Rating:
Buy ARNA
up 76.02 %

Rating:
Hold ARNA

Rating:
Hold ARNA

Your Recent Stocks
SymbolLastChange
ARNA 2.01 down  -24.15 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy